Jaycock Philip D, O'Brart David P S, Rajan Madhavan S, Marshall John
Rayne Institute, Department of Ophthalmology, St. Thomas' Hospital, London, United Kingdom.
Ophthalmology. 2005 Feb;112(2):191-9. doi: 10.1016/j.ophtha.2004.09.017.
To assess the long-term efficacy and stability of LASIK for hyperopia (+0.75 to +7.00 diopters [D]).
Retrospective follow-up study of a previous phase III multicenter clinical trial (unpublished data).
Patients who had been treated for hyperopia (33 individuals, 47 eyes) attended follow-up 5 years after surgery. The preoperative mean spherical equivalent at the spectacle plane was +3.58 D (range, +0.75 to 7.00 D), and the attempted mean spherical correction at the corneal plane was +3.18 D (range, +1.00 to +6.00 D).
Treatments were performed using a Moria LSK One microkeratome and a Summit Technology SVS Apex Plus excimer laser fitted with an Axicon.
Manifest refraction, uncorrected visual acuity, best spectacle-corrected visual acuity, corneal transparency, complications, and patient satisfaction were recorded.
At 5 years, for treatments between +1.00 to +3.00 D, 71.0% of eyes were within +/-1.00 D of the intended correction, and for treatments between +3.5 to +6.0 D, 37.5% of eyes were within +/-1.00 D of intended correction. From 12 to 54 months after surgery for all patients, there was a hyperopic shift of +0.53 D (range, -0.13 to +3.13 D), with 51.1% of eyes experiencing an increase of +0.50 D or more and 27.7% of eyes showing a hyperopic shift of more than +1.00 D. This hyperopic shift was +0.67 D (range, 0 to +1.125 D) for patients younger than 40 years of age and +0.44 D (range, -1.33 to +1.50 D) for patients between 43 and 55 years of age.
LASIK was moderately effective for the correction of low degrees of hyperopia. However, there was regression throughout the 5-year follow-up that was greater than would be expected as a result of aging. Long-term stability of hyperopic LASIK refractive corrections, therefore, is uncertain.
评估准分子激光原位角膜磨镶术(LASIK)治疗远视(+0.75至+7.00屈光度[D])的长期疗效和稳定性。
对之前一项III期多中心临床试验的回顾性随访研究(未发表数据)。
接受远视治疗的患者(33人,47只眼)在术后5年接受随访。术前在眼镜平面的平均等效球镜度为+3.58 D(范围为+0.75至7.00 D),在角膜平面尝试的平均球镜矫正度为+3.18 D(范围为+1.00至+6.00 D)。
使用Moria LSK One微型角膜刀和配备轴锥镜的Summit Technology SVS Apex Plus准分子激光进行治疗。
记录显验光、未矫正视力、最佳眼镜矫正视力、角膜透明度、并发症及患者满意度。
5年时,对于+1.00至+3.00 D之间的治疗,71.0%的眼在预期矫正的±1.00 D范围内;对于+3.5至+6.0 D之间的治疗,37.5%的眼在预期矫正的±1.00 D范围内。在所有患者术后12至54个月期间,出现了+0.53 D的远视漂移(范围为-0.13至+3.13 D),51.1%的眼远视增加+0.50 D或更多,27.7%的眼远视漂移超过+1.00 D。40岁以下患者的这种远视漂移为+0.67 D(范围为0至+1.125 D),43至55岁患者为+0.44 D(范围为-1.33至+1.50 D)。
LASIK治疗低度远视有一定疗效。然而,在整个5年随访期间存在回退,且大于因年龄增长预期的程度。因此,远视LASIK屈光矫正的长期稳定性尚不确定。